Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction

J Electrocardiol. 2005 Jul;38(3):271-8. doi: 10.1016/j.jelectrocard.2005.01.013.

Abstract

Background: The relevance of the atrial coronary anatomy in the pathogenesis of atrial arrhythmias and atrioventricular (AV) block complicating acute myocardial infarction (AMI) remains unclear.

Objectives: We evaluated the location of the infarct-related coronary lesion relative to the principal atrial branches (ie, sinoatrial nodal, AV nodal, left atrial circumflex) in 454 patients with ST-elevation AMI in the CAPTORS II trial.

Methods: Patients underwent systematic 60-minute postfibrinolytic angiograms, and coronary anatomy was correlated with evidence of atrial arrhythmias and AV block on sequential electrocardiograms.

Results: Patients with either sinoatrial nodal or left atrial circumflex compromise (n = 34) had a higher incidence of "early" (ie, up to 90 minutes postfibrinolysis) atrial arrhythmias vs those without (23.5% vs 7.1%; P = .004). Patients with AV nodal compromise (n = 207) had a higher incidence of "early" AV block vs those without (12.1% vs 3.6%; P = .001).

Conclusion: These findings support the etiological role of acute atrial ischemia in the development of early atrial arrhythmias and AV block complicating AMI.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Arrhythmias, Cardiac / etiology*
  • Atrioventricular Node / pathology
  • Bundle-Branch Block / etiology
  • Coronary Angiography
  • Coronary Vessels / pathology*
  • Electrocardiography
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Heart Atria / pathology*
  • Heart Block / etiology*
  • Humans
  • Male
  • Metalloendopeptidases / therapeutic use
  • Middle Aged
  • Myocardial Infarction / complications*
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / pathology
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / pathology
  • Polyethylene Glycols / therapeutic use
  • Sinoatrial Node / pathology

Substances

  • Fibrinolytic Agents
  • Polyethylene Glycols
  • Metalloendopeptidases
  • PEGylated staphylokinase SY161